Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · Real-Time Price · USD
2.450
+0.050 (2.08%)
May 12, 2025, 4:00 PM - Market closed
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $6.24 million as of May 12, 2025. Its market cap has increased by 24.44% in one year.
Market Cap
6.24M
Enterprise Value
4.11M
1-Year Change
24.44%
Ranking
Category
Stock Price
$2.45
Market Cap Chart
Since the IPO on December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from $32.74M to $6.24M, a decrease of -80.92%. That is a compound annual growth rate of -50.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 6.12M | 65.91% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -45.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 370.51B |
| UnitedHealth Group | 343.53B |
| AbbVie | 336.32B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.40B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |